Skip to Main Content

Paper Details

Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast Cancers.
Clin Cancer Res
3
2022
Author NameAffiliation
Joel S ParkerUniversity of North Carolina at Chapel Hill
Joel S ParkerUniversity of North Carolina at Chapel Hill
  • 1 - 2

Datasets

Release 1.2